Trial Profile
Phase I trial of GLG-801 in patients with autosomal dominant polycystic kidney disease
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 04 Mar 2016
Price :
$35
*
At a glance
- Drugs GLG 801 (Primary)
- Indications Autosomal dominant polycystic kidney disease
- Focus Adverse reactions
- Sponsors GLG Pharma
- 04 Mar 2016 New trial record
- 20 Nov 2015 According to GLG Pharma media release, company is planning to initiate this trial in 2016.